Powered Vascular Stapler in Video-Assisted Thoracoscopic (VAT) Lobectomies
October 10, 2018 updated by: Ethicon Endo-Surgery
A Prospective, Randomized, Controlled, Multi-Center Evaluation of a Powered Vascular Stapler in VAT Lobectomies
This prospective, randomized, controlled, multi-center study will collect and compare data from the surgeon's current Standard Of Care stapler (for Pulmonary Artery/Pulmonary Vein transection) and powered vascular stapler.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
201
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Emory University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects with a confirmed or suspected diagnosis of stage IA to stage IIIA non-small cell lung cancer scheduled for a lobectomy (Lung Cancer Staging per American Joint Committee on Cancer,7th Edition)5;
- Subjects scheduled for VATS lobectomy in accordance with their institution's Standard Of Care;
- Performance status 0-1 (Eastern Cooperative Oncology Group classification);
- American Society of Anesthesiologists (ASA) score </= 3;
- No prior history of VAT or open lung surgery (on the lung in which the procedure will be performed);
- Willing to give consent and comply with study-related evaluation and treatment schedule; and
- At least 18 years of age.
Exclusion Criteria
- Prior chemotherapy or radiation (within 30 days prior to the procedure or the duration of the subject's enrollment);
- Pregnancy;
- Physical or psychological condition which would impair study participation; or
- The subject is judged unsuitable for study participation by the Investigator for any other reason.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ethicon Powered Vascular Stapler
|
|
|
Active Comparator: Surgeon's 'standard of care' stapler
Surgeon's current standard of care stapler
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Intra-Operative Hemostatic Intervention
Time Frame: Intra-Operative, an average of 2.3 hours, ranging from 30 mintues to 6.4 hours
|
Incidence of hemostatic interventions/procedures completed for intra-operative bleeding related to the transection of the Pulmonary Artery and Pulmonary Vein during Video Assisted Thoracoscopic lobectomy with the use of standard of care stapler (SOC) or powered vascular stapler (PVS) defined as bleeding detected and controlled intraoperatively (additional stapling, over-sewing, clip placement, compression, use of suture, sealant, and/or buttress, and/or use of energy); or bleeding that occurs intra-operatively requiring blood or blood product transfusion or an additional surgical procedure (e.g.
conversion to open).
|
Intra-Operative, an average of 2.3 hours, ranging from 30 mintues to 6.4 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-operative Interventions or Procedures Related to Pulmonary Artery or Pulmonary Vein Bleeding
Time Frame: Post-Op through 4 Week Followup
|
Incidence of hemostatic interventions /procedures completed for post-operative bleeding related to the transection of the PA and PV during VATS lobectomy with the use of SOC or PVS:
No hemostasis intervention is defined as no interventions needed for post-operative bleeding (related to PA and PV transection). |
Post-Op through 4 Week Followup
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2016
Primary Completion (Actual)
March 31, 2017
Study Completion (Actual)
March 31, 2017
Study Registration Dates
First Submitted
March 2, 2016
First Submitted That Met QC Criteria
March 3, 2016
First Posted (Estimate)
March 9, 2016
Study Record Updates
Last Update Posted (Actual)
October 11, 2018
Last Update Submitted That Met QC Criteria
October 10, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ESC-15-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.